Blood Glucose Monitoring Device Market Growth: Market Size and Analysis
The Blood Glucose Monitoring Device Market Size was valued at USD 12.54 billion in 2022, and is expected to reach USD 23.05 billion by 2030, and grow at a CAGR of 7.9% over the forecast period 2023-2030.
The Bone Graft market has been experiencing a significant surge in recent years, driven by the growing awareness of the potential benefits of CBD for skincare. CBD, or cannabidiol, is a non-psychoactive compound derived from the cannabis plant that is known for its anti-inflammatory and antioxidant properties.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/1013
The glucose monitoring device market has witnessed significant growth in recent years, driven by the increasing prevalence of diabetes worldwide. These devices play a crucial role in managing diabetes by providing accurate and real-time blood glucose level readings.
One of the key factors contributing to the market’s growth is the rising awareness about diabetes and its associated complications. With the growing adoption of sedentary lifestyles, unhealthy eating habits, and an aging population, the number of people diagnosed with diabetes is on the rise. This has led to an increased demand for glucose monitoring devices as individuals strive to effectively manage their condition.
Technological advancements have also played a pivotal role in shaping the glucose monitoring device market. Traditional methods of monitoring blood glucose levels involved invasive procedures such as finger pricking, which were often inconvenient and painful for patients. However, with the advent of non-invasive or minimally invasive devices, such as continuous glucose monitors (CGMs) and flash glucose monitoring systems (FGMs), patients now have access to more comfortable and hassle-free
KEY MARKET SEGMENTS
- Blood Glucose Meter
- Testing Strips
Continuous Blood Glucose Monitoring Devices
- Transmitter & Receiver
- Insulin Pumps
- Home Care
- Diagnostic Centers
Major Players Listed in the Report are as Follows:
Arthrex Inc., Baxter International Inc., Integra Life Sciences Holdings Corporation, Johnson & Johnson (DePuy Synthes), Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive Inc., Stryker Corporation, Xtant Medical Holdings Inc., Zimmer Biomet Holdings Inc. and Other Players.
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)